ENTITY
Cathay Biotech

Cathay Biotech (688065 CH)

50
Analysis
Materials • China
Cathay Biotech Inc. engages in synthetic biology, producing new materials on an industrial scale through bio-manufacturing. The Company focuses on polyamide industry's value chain covering biological long-chain dibasic acid, bio-based pentane diamine, bio-based polyamide, and more. Cathay Biotech markets its products worldwide.
more
•30 Aug 2026 11:15

STAR50 Sep 2026 Index Rebalance: Post-Announcement Positioning

CSI announced five ADDs and five DELETEs on 28 Aug 2026, effective 14 Sep 2026. We review the pre-announcement setup vs prior cycles and potential...

Logo
177 Views
Share
bullish•Arashi Vision
•18 Aug 2026 10:58

STAR50 Sep 2026 Index Rebalance Forecast

We expect 4 High Conviction ADDs and 1 Mid Conviction ADD, against 3 High Conviction DELETEs and 2 Mid Conviction DELETEs on rank shortfall depth.

Logo
163 Views
Share
•21 Jul 2026 16:53

Quiddity Leaderboard STAR 50/100 Sep26: ADDs/DELs Mostly Final; ~US$2bn Combined One-Way Flow

We expect five changes for STAR 50 and most of these names have individual flow sizes larger than US$100mn and have multiple days of volume to trade.

Share
•18 Jun 2026 16:34

Quiddity Leaderboard STAR 50/100 Sep26: Special Focus on Peric (688146) And Sichuan Huafeng (688629)

We see Peric Special Gases (688146 CH) and Sichuan Huafeng Tech (688629 CH) as STAR 100 DELs because they are too large STAR 100 (but not large...

Share
•24 May 2026 10:15

A-Share Margin Trading Weekly (May 22nd): JIANGSU XINQUAN AUTOMOTIVE TRIM, LENS TECHNOLOGY, BOE

We analyzed A-share margin trading positions report for the past week and highlighted JIANGSU XINQUAN AUTOMOTIVE TRIM, LENS TECHNOLOGY, BOE,...

Logo
128 Views
Share
x